ClearBridge Investments
CRL icon

ClearBridge Investments’s Charles River Laboratories CRL Stock Holding History

ClearBridge Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177M Buy
781,276
+148,652
+23% +$26.5M 0.15% 151
2026
Q1 		$109M Buy
632,624
+121,006
+24% +$22.4M 0.1% 198
2025
Q4 		$102M Buy
511,618
+95,619
+23% +$17.3M 0.08% 237
2025
Q3 		$65.1M Buy
415,999
+63,511
+18% +$10.1M 0.05% 294
2025
Q2 		$53.5M Sell
352,488
-336,094
-49% -$44.8M 0.04% 304
2025
Q1 		$104M Sell
688,582
-86,631
-11% -$14.5M 0.09% 221
2024
Q4 		$143M Sell
775,213
-315,779
-29% -$60.8M 0.12% 175
2024
Q3 		$215M Sell
1,090,992
-277,513
-20% -$57.7M 0.17% 130
2024
Q2 		$283M Sell
1,368,505
-144,633
-10% -$32.8M 0.23% 106
2024
Q1 		$410M Buy
1,513,138
+45,079
+3% +$10.8M 0.33% 82
2023
Q4 		$347M Sell
1,468,059
-277,935
-16% -$54.7M 0.3% 87
2023
Q3 		$342M Sell
1,745,994
-4,116
-0.2% -$845K 0.33% 84
2023
Q2 		$368M Buy
1,750,110
+343,076
+24% +$68.3M 0.33% 82
2023
Q1 		$284M Buy
1,407,034
+36,176
+3% +$8.2M 0.27% 99
2022
Q4 		$299M Sell
1,370,858
-78,671
-5% -$17.2M 0.3% 93
2022
Q3 		$285M Sell
1,449,529
-19,153
-1% -$4.13M 0.29% 92
2022
Q2 		$314M Buy
1,468,682
+99,739
+7% +$24.4M 0.29% 89
2022
Q1 		$389M Buy
1,368,943
+301,159
+28% +$92.9M 0.29% 90
2021
Q4 		$402M Buy
1,067,784
+540,217
+102% +$210M 0.27% 92
2021
Q3 		$218M Buy
527,567
+135,189
+34% +$56.1M 0.16% 145
2021
Q2 		$145M Buy
392,378
+104,250
+36% +$34.8M 0.1% 184
2021
Q1 		$83.5M Buy
288,128
+62,023
+27% +$17.2M 0.06% 255
2020
Q4 		$56.5M Buy
226,105
+90,937
+67% +$21.7M 0.04% 314
2020
Q3 		$30.6M Buy
+135,168
New +$28.1M 0.03% 354

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ClearBridge Investments's CRL Position: Q2 2026 in Review

ClearBridge Investments increased its Charles River Laboratories (CRL) stake by 23% in Q2 2026, buying an estimated $26.5M and bringing the position to 781,276 shares worth $177M. The position accounts for 0.15% of the portfolio, ranked #151.

ClearBridge Investments first reported a position in CRL in Q3 2020 and has held it in 24 quarters since. The position peaked at $410M in Q1 2024. 436 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • ClearBridge Investments held 781,276 shares of Charles River Laboratories worth $177M as of Q2 2026.
  • ClearBridge Investments bought 148,652 Charles River Laboratories shares in Q2 2026, an estimated $26.5M.
  • Charles River Laboratories made up 0.15% of ClearBridge Investments's portfolio in Q2 2026, its #151 holding.
  • ClearBridge Investments first reported a position in Charles River Laboratories in Q3 2020 and has held it in 24 quarters since.
  • ClearBridge Investments's Charles River Laboratories position peaked at $410M in Q1 2024.
  • 436 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.